JNPMEDI Signs Strategic Partner with MEDIAIPLUS To Revitalize Global Clinical Trial Data Platform

JNPMEDI
30 Aug 2022 · 3 minutes read

JNPMEDI has signed a strategic partnership agreement with MEDIAIPLUS, which provides a customized and AI/bigdata driven global clinical trial information subscription service "MediC’. The partnership will revitalize the global clinical trial data platform.

Jingon Kim, director of JNPMEDI (left), Joon-hyuk Lee, director of MEDIAIPLUS (right)

JNPMEDI has signed a strategic partnership agreement with MEDIAIPLUS, which provides a customized and AI/bigdata driven global clinical trial information subscription service "MediC’. The partnership will revitalize the global clinical trial data platform.

Through this agreement, business partners who introduced services provided by JNPMEDI and MEDIAIPLUS agreed to provide business and technical support to efficiently use their solutions, while actively sharing know-how in operating clinical trial services.

Mediaiplus, established in 2019, is a startup that provides global clinical trial data analysis and is conducting a data-based web platform construction project in the rapidly increasing field of clinical trials based on long practical experience in the pharmaceutical/bio field.

Jingon Kim, director of JNPMEDI, said, "MEDIAIPLUS is a clinical matching and custom information platform company, that is developing various services to resolve bottlenecks that occur in the process of conducting clinical trials. We will do our best to upgrade clinical trial services by combining the technologies of both companies."

Tags:
JNPMEDI
MEDIAIPLUS

Your Partner for a Successful Journey

JNPMEDI has been putting effort on bringing disruption on healthcare industry via integrating digital technologies to clinical research & trial operations.